Magnitude of metabolic syndrome and its predictors among patients on second-generation antipsychotic drugs at six psychiatry clinics and mental hospitals, in Addis Ababa, Ethiopia, 2019; Multicenter cross-sectional study
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (4) , 102187
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected AntipsychoticsFrontiers in Psychiatry, 2019
- The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative studyBMC Psychiatry, 2018
- Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk FactorsPLOS ONE, 2016
- Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South AfricaBMC Psychiatry, 2014
- Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic HypothesisCNS Drugs, 2013
- The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong – a cross sectional studyBMC Psychiatry, 2013
- Prevalence of metabolic syndrome among patients with Schizophrenia in PalestineBMC Psychiatry, 2012
- Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropicsHuman Psychopharmacology: Clinical and Experimental, 2012
- People living with psychotic illness in 2010: The second Australian national survey of psychosisAustralian & New Zealand Journal of Psychiatry, 2012